Empowering Medicine

with real-time intelligence and insight into the interaction between patients and their medication.

    • Upwards of 30% of patients with common chronic conditions do not take medication as prescribed.
    • Poor medication adherence is a leading cause of avoidable hospital admissions and readmissions.
    • eTect's ID-Cap platform empowers medicine to report when it has been ingested by the patient.
    • eTect's ID-Cap platform enhances clinical research
      • Improved quality of study data
      • Better understanding of patient reactions
      • More efficient, less expensive clinical studies
      • Reach informed decisions more quickly
    • Definitive real-time knowledge of when and if patients are taking study medications.
    • Total pharmacy benefits grew about 2% in 2012; specialty pharmacy benefits grew nearly 20% in the same period.
    • Specialty pharmacy spend is expected to be half of all pharmacy spend by 2018.
    • eTect's ID-Cap platform provides real-time information to manage utilization of these high-cost, high-consequence specialty drugs
      • Detect and manage over or under adherence
      • Gain insight into each patient's reaction and side effects
      • Focus patient outreach from care management teams - intervene only when needed

Follow Us on Twitter @eTectbio

@eTectbio

Empowering Medicine

Press Releases

Press Releases

WHAT WE DO

ID-Cap is a powerful platform for in-body communications.

WHAT WE DO

    • Patient Friendly - the ID-Cap is a standard gelatin or HPMC capsule with an embedded ingestible wireless sensor that holds the patient's medication.  All the patient does is take their medicine - no extra pill to take.  It looks, tastes, and feels just like an ordinary capsule.
    • Medication Friendly - the capsule dissolves just like a normal capsule and does not interact with the medication.
    • Pharmacy and Pharmaceutical Manufacturer Friendly - ID-Caps are the same size as standard capsules so they can be filled in standard capsule filling systems. High-volume automatic filling systems for pharmaceutical manufacturers to make millions of doses or low-volume manual filling systems for pharmacists to use ID-Caps for a single prescription.
    • Reads Every Dose - Full two-way communications between the ID-Cap and the Hub ensure every dose is detected.  The ID-Cap communications technology has demonstrated extremely high reliability in multiple clinical studies.
    • "Self" Powered - the ID-Cap sensor is powered by the patient's own body.
    • Leaves No Trace - After the capsule dissolves, the ultra thin, flexible sensor is naturally eliminated through the patient's GI tract.

    ID-Caps and tag

     

     

     

    • Patient Friendly - does not require any patient configuration or manipulation. Simply put it on and go.
    • Flexible - the core electronics module of the Hub is wearable in multiple form factors to fit the patient's preference.
    • Always Connected - integrates in-body, personal area, and cellular communications.  Eliminates the need to use  the patient's mobile phone to collect data.

    Reader for website

    • Always Up to Date - Real-time patient information provides the most current data
    • Versatile - a conduit for collecting patient data from other on-body sensors
    • Understand Patients Better - integrate data collected by the ID-Cap platform with EMR/EHR, pharmacy records, claims records, public and commercial data to get a complete picture of patient behavior.

    ID-Cap Platform 

HOW ID-CAP HELPS PATIENTS

ID-Cap is currently only available for use in IRB approved clinical research. 

ABOUT US

Our Vision

We envision an era of personalized, connected healthcare; of mobile patients with digital medicine and health devices interconnected in a seamless ecosystem providing a continuous flow of digital health information managed by the patient, leading to better outcomes, lower costs, improved quality of care, and greater quality of life.

Our Mission

eTect strives to be the premier in vivo communications company in the world. To create excellent products that provide unmatched value and benefit to our customers; create significant value for our employees and shareholders; and continually push the limits of technology.  We will always have respect for our employees, our community, and our environment and foster a healthy balance of life for all of our stakeholders through innovation, teamwork, persistence, and fun.

Management Team

ABOUT US

Neil R. Euliano II, Ph.D., Founder, Chief Executive Officer

Dr. Euliano is the founder and CEO at eTect, Inc. He is also a member of the Board of Directors and holds a Ph.D. in Electrical Engineering from the University of Florida. He is the founder and President of Convergent Engineering Inc., a Biomedical Engineering firm in Gainesville Florida and a Courtesy Assistant Professor in the Department of Anesthesiology at the University of Florida. Dr. Euliano was the Vice President of Research and Development at NeuroDimension, Inc. He currently holds twenty-five issued patents, and has been the principal investigator on over $8 million of research funding from NIH, NSF, and industry.

Dr. Euliano also serves on eTect's Board of Directors.

ABOUT US

D. Eric Buffkin Jr., President, Chief Operating Officer

Mr. Buffkin is an entrepreneur and executive with over 20 years of experience in the networking and communications integrated circuits market. He is the founder of Pelagic Group, a consultancy focused on new technology companies. He has also founded or co-founded ventures that span many facets of the wireless semiconductor and communications industry. Mr. Buffkin served as Vice President, Business Development, Sales, and Marketing with Intellon Corporation, now part of Qualcomm. Mr. Buffkin holds a BSEE from the University of Florida and an MBA from Rollins College, Winter Park, Florida.

Mr. Buffkin also serves on eTect's Board of Directors.

ABOUT US

Kimberly A. Ramsey, Chief Financial Officer

Ms. Ramsey has 20 years of progressive corporate finance experience of public and private companies with responsibilities for accounting, finance, information technology, risk management, investor relations, IPO, acquisitions and mergers.  Most recently, she served as a senior-level financial consultant to Fortune 500 companies in North Florida.  She brings 20 years of experience in the medical device, biotechnology and high tech industries. In addition, Ms. Ramsey has significant experience at the executive level with companies in the start-up through IPO phase.  Ms. Ramsey received a bachelor’s of science in accounting from the Fisher School of Accounting at the University of Florida.

ABOUT US

Tony Christopher Carnes, Ph.D. Chief Information Officer

Dr. Carnes leads eTect's information system strategy and architecture. He has more than twenty years of experience in the field of information technology. Prior to joining eTect, he served as Chief Scientist at Covidien, one of the world’s biggest medical companies. He has also been the President and Founder of Carnes consulting and helped move many large companies into the relational database world including NASA, Los Alamos and Sandia National Labs, FCC, FedEx, Circuit City, and Superior Telecommunications. He was the Co-Founder and President of ICU DataSystems, a company that developed patient monitoring, data aggregation, and database solutions for hospitals.

Board of Directors

ABOUT US

Louis H. Oberndorf, Chairman

Louis H. Oberndorf is the Chairman of the Board. He founded Medical Education Technologies, the first company to deliver high-fidelity patient simulation to healthcare education. Prior to that, he served as Vice President of Marketing and Senior Vice President of Business Development for Loral Corporation. Mr. Oberndorf received an MBA in Management from the University of Utah and completed the University of Michigan Senior Management Executive Program. He was presented with S. Clark Butler Entrepreneur of the Year Award by the University of Florida in 2013.

ABOUT US

Neil R. Euliano, ED.D.

Dr. Euliano holds a Doctoral degree in Education and has led educational institutions like Barry University Law School, Southern Technical College, and Florida Tech Systems of Schools and Colleges. He has been elected to the position of trustee for several universities because of his strong leadership skills. He has also served in the U.S. army and is a proud recipient of Outstanding Florida Educator Award for the year 2000. Dr. Euliano received a B.S. from Gannon Catholic University and an M.B.A. and ED.D from the University of Sarasota.

ABOUT US

Charles E. Harris

Mr. Harris serves as Managing Director of Sylva Ventures LLC and Chief Executive Officer of Playoff Technologies LLC, a cloud based software company. He is the former Chief Executive Officer of Intellon Corporation, a fabless semiconductor company that was acquired by Atheros Communications in December 2009. Mr. Harris has also held a variety of executive management roles including Vice Chairman and Chief Financial Officer of Starwood Vacation Ownership, Inc.; President and Chief Executive Officer of Allen C. Ewing & Co., a Florida investment banking firm; Chairman and Chief Executive Officer of Mid-State Federal Savings Bank; and Senior Vice- President and General Counsel of Sun Banks, Inc. Mr. Harris earned a bachelors's degree in political science from the University of Florida and a J.D. from Harvard Law School. He is a member of the Florida Bar and the District of Columbia Bar.

PATIENT IMPACT

MEET DOROTHY

Dorothy is one of 51 percent of people who take more than five prescription drugs everyday. She is 83 and  lives alone. She sees four specialists but visits only one pharmacy for all her prescriptions. Her daughter, Emily, lives 200 miles away and is worried about her well- being. It is important for Emily to know that Dorothy is taking all her medications in time.

For Dorothy and Emily, ID-Cap system will provide an easy solution. ID-Cap will verify ingestion of medicine in real time and will send a signal to Dorothy through the hub. The adherence verification will also be available to Emily in real time through the mobile data network. The ID-Cap system will enable Dorothy's physicians to access the complete information on her medications, thereby, lowering the chance of medication errors. Her pharmacist will be able to pull up her medication and adherence records and make sure that the medicines are not being misused. Improved medication adherence will mean better treatment outcomes for Dorothy, peace of mind for Emily, and optimal use of time for her physicians and pharmacists.

Go to Jasmine, Deonte, or Mike.

MEET JASMINE

A 24 year old mechanical engineer, Jasmine, recently received a kidney transplant.  Her post-operative care includes immunosuppressants which must be taken everyday, in the exact amounts as prescribed  Even the slightest change from the medication regimen can trigger organ rejection. While the need for medications will eventually decrease, Jasmine will still be on atleast one immunosuppressant for her lifetime. 

Jasmine's pharmacist calls her on a regular basis to check on her health and medications. He recently told her about the ID-Cap system and how it would help him track her medication behavior in real time. Access to adherence information through this customer centric technology would make him more competent in his job. He would have the ability to intervene in real time, thereby helping patients improve their medication adherence. Improved adherence would lead to better treatment outcomes, which in turn, would lower the chance of hospital re-admission.

Go to Dorothy, Deonte, or Mike.

MEET DEONTE

Deonte is an active 6th grader who enjoys football and beating his older brothers in Madden NFL. His life recently changed when he was diagnosed with epilepsy. This means  Deonte and his family will likely spend the next 2-5 years working with their doctors to determine the treatment or combination of treatments to best control his condition.

Drug companies are creating exciting new agents to treat central nervous system disorders and diseases like epilepsy. ID-Cap will allow drug developers to collect and coordinate much more and far better data about their patients in less time.  This translates to better understanding of drug profiles, shorter and less expensive drug development, and ultimately, more effective and safer treatment options for patients like Deonte.

Go to Dorothy, Jasmine, or Mike.

MEET MIKE

55 years old Mike has a family history of cardiovascular disease and was diagnosed with chronic hypertension about a year ago. He has been on four different prescriptions in the last one year but none of them have had desirable results. His physician is not sure why the medications are not working for him and wants to investigate the reason behind it. She suspects that Mike is not taking all his doses as prescribed because of which the medications are not being effective.

Mike's physician has decided to get real time verifiable data on his medication behavior. She has prescribed him a new drug with the ID-Cap system. In case, Mike misses a dose, she can intervene and help him get more adherent with the medication. This time, if the medicines do not work, she will be be able to assess the drug's performance timely and objectively.

Go to Dorothy, Jasmine, or Deonte.

NEWS

eTect wins SXSW V2V’s Health Category

  July 18, 2014, Las Vegas, NV – eTect, Inc. took home the first prize in the Health and Wearable Technologies category at the second annual V2Venture competition at SXSW V2V held at The Cosmopolitan of Las Vegas. The V2Venture competition honored five of the most exciting new innovations in five categories including Education Technologies; Health and(…)

Charles E. Harris joins eTect Board of Directors

Gainesville, FL, April 28, 2014- eTect, Inc. announced today the appointment of Charles E. Harris as the newest addition to their Board of Directors effective immediately. Mr. Harris will augment the board with his executive management accomplishments and exceptional leadership qualities.”We are excited to have Charlie on the board”, said Lou Oberndorf, Chairman of the Board.(…)

eTect awarded $1m for 2nd phase of NIDA program

Gainesville, FL- April 14, 2014- eTect announced today it has been authorized to move ahead on the second phase of it’s “Fast Track” SBIR grant by theNational Institute on Drug Abuse (NIDA). Phase 2 of the NIDA program will provide $1,000,000 of research support for product development and clinical testing of the ID-Cap system. The ID-Cap is a standard HPMC or(…)

CONNECT

Your Name (required)

Your Email (required)

Subject

Your Message

Prove that you are human! Enter the word below.

captcha



We respect your privacy and do not share your information with third parties.

 

 

Mailing Address:

107 SW 140th Terrace, Suite 1, Newberry, FL 32669

Phone: 352.367.8328, Ext 103

Email: info@etectbio.com

Fax: 352-378-9202

For Investor Information:

Please submit the form on left with the subject line  

as "Investor Information." Our Investor Relations

team  will contact you shortly.

BLOG

The Institute for Commercialization of Public Research ignites innovation in healthcare

The Institute for Commercialization of Public Research ignites innovation in healthcare

With members of the business, academic, non-profit and government sectors seeking new and innovative ways to expand local economies and compete globally, universities can lead the collaborative effort to address many of the challenges society faces today. Florida universities contribute significantly to the local economy by employing tens of thousands and educating hundreds of thousands(…)

Our Message to the Healthcare Industry: Take the Meeting!

Our Message to the Healthcare Industry: Take the Meeting!

“Growing a sustainable business in healthcare is different. Growing a sustainable business in healthcare is hard.” I say this all of the time: to myself, to Healthbox entrepreneurs and to our industry partners. It is not for a lack of talented companies with promising solutions. From eTect, which is revolutionizing medication compliance, to CareSpotter, which(…)